Biocence is the only FDA registered human drug, Rx or OTC, that has been granted listing by the FDA as a botanical “Multi-use” category class 1 human drug. This listing has been granted to Biocence because of its recognized and validated “Pan-microbiocidal” efficacy and its application-safety in the “active clinical treatment” of “broken-skin” lesions, ie: severe burns, lacerations, ulcerations, trauma maladies, post-op SSI’s, ostomy care and post-amputee stump asepsis.
Biocence is a unique, incomparable and “stand alone,” “Selective Antibacterial, Antiviral,” over the counter (OTC) Human Drug that has shown in repetitive 3rd party USA BSL 2, 3, and 4 independent laboratory challenges, its 30 second or less “kill times” on ALL pathogenic Bacterial/Fungal Phyla and all VII viral groups, while supporting beneficial microbes.
Innovative Technology Award
Biocence has been hand-selected by an independent Wound Council which consist of seasoned RN Wound, Ostomy and Continence Nurses (WOCN) along with Clinician's, whom collectively concluded that Biocence demonstrates improved clinical outcomes to patients and there are no other similar products on the market.